CRO의 바이오 분석 시험 서비스 시장 규모, 점유율, 동향 분석 보고서 : 분자별, 시험별, 워크플로우별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Bioanalytical Testing Services In CRO Market Growth & Trends:

The global bioanalytical testing services in CRO market size is expected to reach USD 5.62 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 9.02% over the forecast period. The market growth is primarily driven by rising drug development, increased outsourcing, and stringent regulatory requirements. Pharmaceutical and biopharmaceutical companies are increasingly depending on CROs to optimize costs, enhance efficiency, and meet global compliance standards. Further, advancements in bioanalytical technologies, such as high-throughput mass spectrometry and automation, are improving testing accuracy and speed, thereby accelerating market growth potential in near future.

The increasing number of new drug development, particularly for biologics, biosimilars, and gene therapies, is a key driver for the market. Pharmaceutical and biopharmaceutical companies are outsourcing bioanalytical testing to specialized CROs to streamline operations, reduce costs, and accelerate regulatory approvals. The growing complexity of drug molecules necessitates advanced analytical methods, driving demand for high-quality bioanalytical services. Additionally, small and mid-sized pharma firms, lacking in-house expertise, are increasingly relying on CROs for comprehensive testing solutions. This outsourcing trend is further boosted by the need for specialized assays, compliance with stringent global regulations, and faster turnaround times. As R&D investments rise, the dependence on CROs for bioanalytical testing continues to grow, thereby strengthening market expansion in near future.

Furthermore, stringent regulatory guidelines by several authorities such as the FDA, EMA, and ICH implement strict guidelines for bioanalytical testing to enhance drug safety, efficacy, and quality. Growing need for compliance with Good Laboratory Practices (GLP) and evolving bioanalytical method validation requirements will drive demand for specialized CRO services. Moreover, frequent regulatory updates necessitate continuous adaptation, pushing pharmaceutical companies to collaborate with experienced CROs with established compliance frameworks. The increasing scrutiny on pharmacokinetics, bioavailability, and biomarker analysis further accelerates the market growth.

Technological innovations in bioanalytical testing, such as high-throughput mass spectrometry, chromatography, and ligand-binding assays to enhance testing efficiency and accuracy will likely to drive market growth. Moreover, the integration of real-time monitoring and cloud-based platforms to optimize data integrity and regulatory compliance will boost customer preference towards bioanalytical testing services CRO market. The rise of novel therapeutic modalities like cell and gene therapies requires specialized bioanalytical techniques, further expanding CRO service portfolios.

Several key service providers such as ICON Plc., Charles River Laboratories, Syneos Health, SGS SA, LabCorp, etc. operating in the bioanalytical testing services in CRO industry is implementing several strategic initiatives to broaden their service offerings. For instance, in August 2023, Pace Analytical Services announced the acquisition of Alpha Analytical, adding new capabilities such as advanced hydrocarbon analytical support along with expanded sediment & tissue testing. Such acquisitions broadened company's offerings in the market.

Bioanalytical Testing Services In CRO Market Report Highlights:

• Based on molecule, small molecule segment dominated the market primarily attributed to large number of small molecules in drug development. Stringent regulatory requirements for pharmacokinetics and bioequivalence studies will drive the segmental demand.
• Based on the test, bioavailability test held the largest market share in 2024, regulatory agencies require comprehensive pharmacokinetic data, increasing demand for bioanalytical testing. Innovations in analytical methodologies enhance accuracy, ensuring drug formulations meet safety and performance standards, further strengthening this segment.
• Based on workflow, sample analysis segment held the largest market share in 2024due to its critical role in pharmacokinetics, toxicology, and biomarker studies. Advanced analytical techniques, including chromatography and immunoassays, improve detection sensitivity and regulatory compliance. Growing biologics and biosimilars development further bolster demand for precise and high-throughput sample analysis services.
• Based on end use, pharma and biopharma companies segment held the largest market share in 2024due to increasing R&D investment in biologics and personalized medicine further drives market demand. Advanced analytical technologies and regulatory expertise enable CROs to support complex testing needs, strengthening their market presence.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
  • 1.5.1. Region Wise Market: Base Estimates
  • 1.5.2. Global Market: CAGR Calculation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis (Model 1)
  • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.6.4. Bottom-Up Approach (Model 4)
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Increasing Clinical Research To Boost Demand For Outsourcing Services
    • 3.3.1.2. Increasing Adoption Of Advanced Technologies
    • 3.3.1.3. Increasing Mergers and Collaborations
    • 3.3.1.4. Increasing Demand For Outsourcing Services Across The Developing Economies
    • 3.3.1.5. Patent Cliff
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Quality issues of CRO services
    • 3.3.2.2. Intellectual property rights issues
• 3.4. Technological Advancements
  • 3.4.1. Integration of AI and digital technologies
• 3.5. Pricing Model Analysis
• 3.6. R&D Investment Perspective, by Sponsors
• 3.7. Clinical Trials Volume Analysis, 2024
  • 3.7.1. Total Number of Clinical Trials, by Region (2024)
  • 3.7.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.7.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.7.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.8. Market Analysis Tools
  • 3.8.1. Porter's Five Forces Analysis
  • 3.8.2. PESTEL by SWOT Analysis
  • 3.8.3. COVID-19 Impact Analysis

Chapter 4. Bioanalytical Testing Services in CRO Market: Molecule Estimates & Trend Analysis

• 4.1. Bioanalytical Testing Services in CRO Market, By Molecule: Segment Dashboard
• 4.2. Bioanalytical Testing Services in CRO Market, By Molecule: Movement Analysis
• 4.3. Bioanalytical Testing Services in CRO Market Estimates & Forecasts, By Molecule, 2018 - 2030
• 4.4. Small Molecule
  • 4.4.1. Small Molecule Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.5. Large Molecule
  • 4.5.1. Large Molecule Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.5.2. LC-MS Studies
    • 4.5.2.1. LC-MS Studies Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.5.3. Immunoassays
    • 4.5.3.1. Immunoassays Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
    • 4.5.3.2. Pharmacokinetics (PK)
      • 4.5.3.2.1. Pharmacokinetics (PK) Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
    • 4.5.3.3. ADA Assay
      • 4.5.3.3.1. ADA Assay Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
    • 4.5.3.4. Others
      • 4.5.3.4.1. Others Large Molecule Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1. Others Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Bioanalytical Testing Services in CRO Market: Test Estimates & Trend Analysis

• 5.1. Bioanalytical Testing Services in CRO Market, By Test: Segment Dashboard
• 5.2. Bioanalytical Testing Services in CRO Market, By Test: Movement Analysis
• 5.3. Bioanalytical Testing Services in CRO Market Estimates & Forecasts, By Test, 2018 - 2030
• 5.4. ADME
  • 5.4.1. ADME Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 5.4.2. In-Vivo
    • 5.4.2.1. In-Vivo Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 5.4.3. In-Vitro
    • 5.4.3.1. In-Vitro Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.5. Pharmacokinetics (PK)
  • 5.5.1. Pharmacokinetics (PK) Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.6. Pharmacodynamics (PD)
  • 5.6.1. Pharmacodynamics (PD) Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.7. Bioavailability
  • 5.7.1. Bioavailability Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.8. Bioequivalence
  • 5.8.1. Bioequivalence Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.9. Biomarker Testing
  • 5.9.1. Biomarker Testing Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.10. Cell-based Assay
  • 5.10.1. Cell-based Assay Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.11. Virology Testing
  • 5.11.1. Virology Testing Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.12. Others
  • 5.12.1. Others Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Bioanalytical Testing Services in CRO Market: Workflow Estimates & Trend Analysis

• 6.1. Bioanalytical Testing Services in CRO Market, By Workflow: Segment Dashboard
• 6.2. Bioanalytical Testing Services in CRO Market, By Workflow: Movement Analysis
• 6.3. Bioanalytical Testing Services in CRO Market Estimates & Forecasts, By Workflow, 2018 - 2030
• 6.4. Sample Collection and Preparation
  • 6.4.1. Sample Collection and Preparation Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.4.2. Sample Collection, Handling and Storage
    • 6.4.2.1. Sample Collection, Handling and Storage Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.4.3. Protein Precipitation
    • 6.4.3.1. Protein Precipitation Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.4.4. Liquid-Liquid Extraction
    • 6.4.4.1. Liquid-Liquid Extraction Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.4.5. Solid Phase Extraction
    • 6.4.5.1. Solid Phase Extraction Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.4.6. Others
    • 6.4.6.1. Others Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.5. Method Development and Validation
  • 6.5.1. Method Development and Validation Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.6. Sample Analysis
  • 6.6.1. Sample Analysis Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.6.2. Hyphenated Technique
    • 6.6.2.1. Hyphenated Technique Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.6.3. Chromatographic Technique
    • 6.6.3.1. Chromatographic Technique Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.6.4. Electrophoresis
    • 6.6.4.1. Electrophoresis Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.6.5. Ligand Binding Assay
    • 6.6.5.1. Ligand Binding Assay Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.6.6. Mass Spectrometry
    • 6.6.6.1. Mass Spectrometry Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.6.7. Spectroscopic Techniques
    • 6.6.7.1. Spectroscopic Techniques Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
    • 6.6.7.2. Nuclear Magnetic Resonance (NMR)
      • 6.6.7.2.1. Nuclear Magnetic Resonance (NMR) Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
    • 6.6.7.3. Others
      • 6.6.7.3.1. Others Large Molecule Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 6.6.8. Genomic and Molecular Techniques
    • 6.6.8.1. Genomic and Molecular Techniques Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
    • 6.6.8.2. Polymerase Chain Reaction (PCR)
      • 6.6.8.2.1. Polymerase Chain Reaction (PCR) Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
    • 6.6.8.3. Next-Generation Sequencing (NGS)
      • 6.6.8.3.1. Next-Generation Sequencing (NGS) Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
    • 6.6.8.4. Others
      • 6.6.8.4.1. Others Large Molecule Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.7. Other Workflow Process
  • 6.7.1. Other Workflow Processes Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 7. Bioanalytical Testing Services in CRO Market: End Use Estimates & Trend Analysis

• 7.1. Bioanalytical Testing Services in CRO Market, By End Use: Segment Dashboard
• 7.2. Bioanalytical Testing Services in CRO Market, By End Use: Movement Analysis
• 7.3. Bioanalytical Testing Services in CRO Market Estimates & Forecasts, By End Use, 2018 - 2030
• 7.4. Pharma & Biopharma Companies
  • 7.4.1. Pharma & Biopharma Companies Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.5. Academic & Research Institutes
  • 7.5.1. Academic & Research Institutes Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 8. Bioanalytical Testing Services in CRO Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. North America Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Sweden Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.8. Norway
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Norway Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Denmark Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.10. Switzerland
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competitive Scenario
    • 8.5.10.3. Regulatory Framework
    • 8.5.10.4. Switzerland Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.11. Netherlands
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competitive Scenario
    • 8.5.11.3. Regulatory Framework
    • 8.5.11.4. Netherlands Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Japan Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. China Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Australia Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Thailand Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.8. Taiwan
    • 8.6.8.1. Key Country Dynamics
    • 8.6.8.2. Competitive Scenario
    • 8.6.8.3. Regulatory Framework
    • 8.6.8.4. Taiwan Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.9. Indonesia
    • 8.6.9.1. Key Country Dynamics
    • 8.6.9.2. Competitive Scenario
    • 8.6.9.3. Regulatory Framework
    • 8.6.9.4. Indonesia Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.10. Malaysia
    • 8.6.10.1. Key Country Dynamics
    • 8.6.10.2. Competitive Scenario
    • 8.6.10.3. Regulatory Framework
    • 8.6.10.4. Malaysia Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.11. Singapore
    • 8.6.11.1. Key Country Dynamics
    • 8.6.11.2. Competitive Scenario
    • 8.6.11.3. Regulatory Framework
    • 8.6.11.4. Singapore Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.7.4. Colombia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Colombia Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.6. Israel
    • 8.8.6.1. Key Country Dynamics
    • 8.8.6.2. Competitive Scenario
    • 8.8.6.3. Regulatory Framework
    • 8.8.6.4. Israel Bioanalytical Testing Services in CRO Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Participant's overview
  • 9.2.1. Thermo Fisher Scientific Inc.
    • 9.2.1.1. Company Overview
    • 9.2.1.2. Financial Performance
    • 9.2.1.3. Service Benchmarking
    • 9.2.1.4. Strategic Initiatives
  • 9.2.2. ICON Plc
    • 9.2.2.1. Company Overview
    • 9.2.2.2. Financial Performance
    • 9.2.2.3. Service Benchmarking
    • 9.2.2.4. Strategic Initiatives
  • 9.2.3. Charles River Laboratories International
    • 9.2.3.1. Company Overview
    • 9.2.3.2. Financial Performance
    • 9.2.3.3. Service Benchmarking
    • 9.2.3.4. Strategic Initiatives
  • 9.2.4. WuXi AppTec
    • 9.2.4.1. Company Overview
    • 9.2.4.2. Financial Performance
    • 9.2.4.3. Service Benchmarking
    • 9.2.4.4. Strategic Initiatives
  • 9.2.5. IQVIA
    • 9.2.5.1. Company Overview
    • 9.2.5.2. Financial Performance
    • 9.2.5.3. Service Benchmarking
    • 9.2.5.4. Strategic Initiatives
  • 9.2.6. Syneos Health
    • 9.2.6.1. Company Overview
    • 9.2.6.2. Financial Performance
    • 9.2.6.3. Service Benchmarking
    • 9.2.6.4. Strategic Initiatives
  • 9.2.7. SGS SA
    • 9.2.7.1. Company Overview
    • 9.2.7.2. Financial Performance
    • 9.2.7.3. Service Benchmarking
    • 9.2.7.4. Strategic Initiatives
  • 9.2.8. LabCorp
    • 9.2.8.1. Company Overview
    • 9.2.8.2. Financial Performance
    • 9.2.8.3. Service Benchmarking
    • 9.2.8.4. Strategic Initiatives
  • 9.2.9. Intertek Group Plc
    • 9.2.9.1. Company Overview
    • 9.2.9.2. Financial Performance
    • 9.2.9.3. Service Benchmarking
    • 9.2.9.4. Strategic Initiatives
  • 9.2.10. Pace Analytical Services LLC
    • 9.2.10.1. Company Overview
    • 9.2.10.2. Financial Performance
    • 9.2.10.3. Service Benchmarking
    • 9.2.10.4. Strategic Initiatives